International Clinical Trial: Neuronavigated TMS targeting regulation of FPCN subnetwork for attention deficit in adolescents with major depressive disorder: a study of efficacy and safety

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133455) titled 'Neuronavigated TMS targeting regulation of FPCN subnetwork for attention deficit in adolescents with major depressive disorder: a study of efficacy and safety' on Sept. 28.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The first hospital of Shanxi Medical University

Condition: Adolescent major depressive disorder with attention impairment

Intervention: Control group:Single-target real TMS at left DLPFC plus sham stimulation at individual target

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Control group:45;Experiment...